Skip to content
AdobeStock_463675569

DOGS NOW HAVE UP TO 21 DAYS AFTER ENTERING CHF TO SCREEN FOR THE STUDY

We Are Currently Accepting Dogs in a Clinical Study for Congestive Heart Failure Due to Mitral Valve Disease.

Check this info page or contact us through the form at the bottom of the page to learn how your dog can enroll.

Study Purpose

Congestive heart failure due to mitral valve disease is the most common cardiovascular disease in dogs. If left untreated, it could lead to tissue damage or spread to other organs.  We are currently accepting dogs in a clinical trial to investigate a potential new way of managing congestive heart failure due to mitral valve disease. 

This study will evaluate the safety and effectiveness of the management of congestive heart failure due to mitral valve disease in dogs.

Access to a potential new way to manage their congestive heart failure
The opportunity to be part of medical innovations for veterinary science
Eligible for compensation

What Will Happen in The Study?

There will be:

  • Physical examinations
  • Radiographs
  • Echocardiogram
  • Lab work
  • Study treatment
  • 6 in person visits over the course of approximately 3 months

Is My Pet Eligible to Enroll?

*Requirements for Eligibility to Participate Include (but aren’t limited to):

  • Dog has been diagnosed with congestive heart failure due to mitral valve disease
  • Dog cannot have a concurrent condition or disease that could interfere with study objectives
  • Dog cannot be pregnant or lactating, or intended for breeding during the study
  • Dog must meet mandatory washout period
  • Dog must have received Furosemide, Pimobendan, ACE inhibitor and Spironolactone for at least 10 continuous days prior to Study Day 0.

*Please talk to the study veterinarian for more information.

Compensation

The study covers all related costs, including:

Physical exams

Lab work

Study Treatment